The authors found that these allergens, through the activation of metalloproteinases (MMP) and the epithelial growth factor receptor (EGFR), lead to an overexpression of this cytokine, leading to a Th2 response capable of inducing, in vivo, AD manifestations via the decreased production of filaggrin [32]. This evidence concerns the gene FLG and Alzheimer disease.